BIOVAIL SUES FDA

Canadian drug maker Biovail Corp. said Thursday it is suing the U.S. Food and Drug Administration to try to stop the agency from approving generic versions of its extended-release antidepressant without addressing issues brought up in a citizen petition.
MSN Money